纳米粒子介导的耐药性和补偿基因的辅助沉默增强了肺癌治疗方法
Dhananjay Suresh1,2, Soumavo Mukherjee1, Ajit Zambre2
1Department of Bioengineering, University of Missouri, Columbia, Missouri 65212, United States.
ACS nano
|April 16, 2025
概括
这项研究开发了携带siRNA的凝纳米粒子,以使AXL和FN14基因沉默,克服非小细胞肺癌 (NSCLC) 的耐药性,并减少瘤生长.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 分子生物学分子生物学
背景情况:
- 由于获得的耐药性,非小细胞肺癌 (NSCLC) 带来了治疗挑战,特别是表皮生长因子受体 (EGFR) 氨酸激酶抑制剂 (TKIs).
- AXL过度表达是超过25%的NSCLC患者TKI耐药性的关键机制.
- 抑制AXL可以导致FN14信号的补偿上调,从而可能限制治疗疗效.
研究的目的:
- 评估在NSCLC中同时静止AXL和FN14基因的治疗疗效.
- 开发一种基于纳米粒子的短干扰RNA (siRNA) 传递系统,针对AXL和FN14.
- 在NSCLC模型中克服TKI耐药性和减少瘤生长.
主要方法:
- 开发装载着针对AXL和FN14 (GsiAF) 的siRNA的凝纳米颗粒.
- 在体外和体内对GsiAF进行基因沉默和克服补偿信号的评估.
- 在NSCLC细胞和小鼠模型中对GsiAF与TKI治疗相结合的评估.
主要成果:
- 在体外和体内,GsiAF有效地选择性地使AXL和FN14基因沉默.
- 纳米结构成功地将siRNA传递到瘤中,降低目标基因的调节,克服FN14补偿信号.
- 对AXL和FN14的联合抑制显著降低了癌细胞中的TKI抵抗力,并减少了体内瘤的生长.
结论:
- 开发的凝-siRNA纳米结构 (GsiAF) 是克服NSCLC中TKI耐药性的有希望的策略.
- 通过纳米颗粒传递siRNA同时准AXL和FN14,提供了一个潜在的治疗方法.
- 这种组合疗法在治疗NSCLC和其他癌症方面具有临床翻译的潜力.
更多相关视频
11:44Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
7.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.1K
相关概念视频
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K